<DOC>
	<DOCNO>NCT02141139</DOCNO>
	<brief_summary>It increasingly recognize NSAIDS ( nonsteroidal antiinflammatory drug ) might prevent several cancer . In breast cancer , role NSAIDS ( nonsteroidal antiinflammatory drug ) suggested.However , consistent result . surgery main cause inflammation cancer patient . Therefore , want know association prevention perioperative inflammation NSAIDS breast cancer outcome .</brief_summary>
	<brief_title>Perioperative Inflammation Breast Cancer Outcome</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Breast cancer patient take surgery underlie medical disease ( major heart disease , lung disease , coagulopathy ) major psychologic disease ( major depression , schizophrenia , manic disorder ) pregnancy rheumatic disease patient</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Perioperative Period</keyword>
</DOC>